Form N-CEN MFS INTERMEDIATE HIGH For: Nov 30
Tweet
Share
E-mailATTACHMENTS / EXHIBITS
NCEN_811-05567_26456133_1125.htm
NCEN_811-05567_35996497_1125.htm
NCEN_811-05567_38088592_1125.htm
NCEN_811-05567_40576983_1125.htm
NCEN_811-05567_46149669_1125.htm
NCEN_811-05567_49106660_1125.htm
NCEN_811-05567_54841178_1125.htm
NCEN_811-05567_69391744_1125.htm
NCEN_811-05567_77886645_1125.htm
NCEN_811-05567_81183866_1125.htm
NCEN_811-05567_87528089_1125.htm
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Certain MFS Closed-End Funds Announce Closing Date for Reorganization and Change of Investment Adviser
- Dayspring Pharma Announces Positive Topline Results from Phase II Clinical Trial of CG2001 for the Treatment of Androgenetic Alopecia (AGA)
- Antengene Presented First Preclinical Data at EULAR 2026 Showing ATG-207 Promotes Regulatory T Cell Induction and Immune Tolerance
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
